| Income Statement | 2025-09-30 | |||
|---|---|---|---|---|
| Research and development | 993,066 | |||
| General and administrative | 803,619 | |||
| Total operating expenses | 1,796,685 | |||
| Loss from operations | -1,796,685 | |||
| Interest income | 11,627 | |||
| Other income, net | 11,627 | |||
| Net loss | -1,785,058 | |||
| Earnings per share, basic | -0.1 | |||
| Earnings per share, diluted | -0.1 | |||
| Weighted average number of shares outstanding, basic and diluted | 17,082,425 | |||
| Weighted average number of shares outstanding, diluted | 17,082,425 | |||
NANOVIRICIDES, INC. (NNVC)
NANOVIRICIDES, INC. (NNVC)